BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eindor-Abarbanel A, Healey GR, Jacobson K. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood. Int J Mol Sci 2021;22:12506. [PMID: 34830388 DOI: 10.3390/ijms222212506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wei Y, Song D, Wang R, Li T, Wang H, Li X. Dietary fungi in cancer immunotherapy: From the perspective of gut microbiota. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1038710] [Reference Citation Analysis]
2 Becker HEF, Demers K, Derijks LJJ, Jonkers DMAE, Penders J. Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease. Front Microbiol 2023;14:1107976. [PMID: 36910207 DOI: 10.3389/fmicb.2023.1107976] [Reference Citation Analysis]
3 Huang Z, Liu K, Ma W, Li D, Mo T, Liu Q. The gut microbiome in human health and disease-Where are we and where are we going? A bibliometric analysis. Front Microbiol 2022;13:1018594. [PMID: 36590421 DOI: 10.3389/fmicb.2022.1018594] [Reference Citation Analysis]
4 Cornelia Lazăr D, Moacă E, Cornianu M, Tăban S, Faur A, Goldiș A. Efficiency of Treatment Targeted on Gut Microbiota in Inflammatory Bowel Diseases: Current Strategies and Perspectives. Benign Anorectal Disorders - An Update [Working Title] 2022. [DOI: 10.5772/intechopen.108664] [Reference Citation Analysis]
5 Cheng T, Xu C, Shao J. Updated immunomodulatory roles of gut flora and microRNAs in inflammatory bowel diseases. Clin Exp Med 2022. [DOI: 10.1007/s10238-022-00935-9] [Reference Citation Analysis]
6 Vakili B, Shoaei P, Esfandiari Z, Davar Siadat S. Gut Microbiota and Inflammatory Bowel Disease. Effect of microbiota on Health and disease [Working Title] 2022. [DOI: 10.5772/intechopen.105842] [Reference Citation Analysis]
7 Rutter JW, Dekker  L, Owen  KA, Barnes  CP. Microbiome engineering: engineered live biotherapeutic products for treating human disease. Front Bioeng Biotechnol 2022;10:1000873. [DOI: 10.3389/fbioe.2022.1000873] [Reference Citation Analysis]
8 Zhang S, Jin W, Zhang W, Ren F, Wang P, Liu N. Pea Albumin Attenuates Dextran Sulfate Sodium-Induced Colitis by Regulating NF-κB Signaling and the Intestinal Microbiota in Mice. Nutrients 2022;14:3611. [DOI: 10.3390/nu14173611] [Reference Citation Analysis]
9 Xu P, Lv T, Dong S, Cui Z, Luo X, Jia B, Jeon CO, Zhang J. Association between intestinal microbiome and inflammatory bowel disease: insights from bibliometric analysis. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 El-sahhar S, Varga-weisz P. The gut microbiome in health and disease: Inflammatory bowel diseases. Advances in Ecological Research 2022. [DOI: 10.1016/bs.aecr.2022.09.005] [Reference Citation Analysis]